Paper-based methods and drugs are not the only two options we have for the diagnosis of dementia, expert says. With cognitive screening methods and AI-powered testing, early detection of dementia, Alzheimer’s, and cognitive impairment, better results can be acquired, informs David Bates, CEO of Linus Health. He believes that neurocognitive health interventions should be personalised and multidimensional. AI-based tools and devices can diagnose symptoms of dementia such as early decline better than human diagnosis. During the interview, Bates argued that since brain is a complex organ, neurocognitive interventions need to be multifaceted.
Read More from HealthcareITNews